Lenalidomide
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6970 publications
Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey study.
Journal: Future oncology (London, England)
Published: April 13, 2026
Intelligent α-Cyclodextrin-Based Nanomachines Co-loading Lenalidomide and Au@TPE for NIR-I-Light Programmed Combinatorial Breast Cancer Therapy.
Journal: ACS applied bio materials
Published: April 07, 2026
Lenalidomide exposure duration and drug holidays do not affect stem cell mobilisation with plerixafor and G-CSF in multiple myeloma.
Journal: Leukemia & lymphoma
Published: April 01, 2026
Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report.
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: March 31, 2026
Two successful thrombectomies in a patient with thrombocytopenia
Journal: Ideggyogyaszati szemle
Published: March 28, 2026
POEMS Syndrome Presenting as Porto-Sinusoidal Vascular Disease: A Case Report.
Journal: Clinics and research in hepatology and gastroenterology
Published: March 18, 2026
Early intervention for high-risk smoldering multiple myeloma (SMM).
Journal: The Cochrane database of systematic reviews
Published: March 18, 2026
Neutrophil extracellular trap-related genes in PTCL: identification, prognosis and drug interaction prediction via bioinformatics-machine learning.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 03, 2026
A Cross-sectional Exploratory Study on Symptom Correlations in Multiple Myeloma Patients During Initial Treatment Using the Edmonton Symptom Assessment System.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: March 01, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2026
Comparative cost per responder analysis of ciltacabtagene autoleucel and real-world standard of care therapy in patients with lenalidomide-refractory multiple myeloma.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: February 24, 2026
Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma.
Journal: Journal of medical cases
Published: February 23, 2026
Last Updated: 04/28/2026